KYMERA THERAPEUTICS, INC. Earnings Per Share (Diluted)
KYMERA THERAPEUTICS, INC. (KYMR) reported Earnings Per Share (Diluted) of -$0.62 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.62.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.71.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $5.95, a 26.61% increase year-over-year.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.94.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was -$3.69.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was -$2.98.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$2.52.
- KYMERA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$2.87.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.62 10-Q · filed 2026-08-05 | -$1.33 10-Q · filed 2026-08-05 | $4.26 derived: net income ÷ weighted average shares · filed 2026-08-05 | $3.46 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.71 10-Q · filed 2026-04-30 | $4.97 derived: net income ÷ weighted average shares · filed 2026-04-30 | $4.19 derived: net income ÷ weighted average shares · filed 2026-04-30 | $3.46 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $5.95 derived: net income ÷ weighted average shares · filed 2026-04-29 | $5.12 derived: net income ÷ weighted average shares · filed 2026-04-29 | $4.39 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$3.69 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.94 10-Q · filed 2025-11-04 | -$1.89 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.71 10-Q · filed 2025-11-04 | $1.86 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.95 10-Q · filed 2026-08-05 | -$1.77 10-Q · filed 2026-08-05 | $2.93 derived: net income ÷ weighted average shares · filed 2026-08-05 | $2.17 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.82 10-Q · filed 2026-04-30 | $3.88 derived: net income ÷ weighted average shares · filed 2026-04-30 | $3.16 derived: net income ÷ weighted average shares · filed 2026-04-30 | $2.67 derived: net income ÷ weighted average shares · filed 2026-04-30 |
| 2024-12-31 | $4.70 derived: net income ÷ weighted average shares · filed 2026-04-29 | $4.02 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.56 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.98 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.82 10-Q · filed 2025-11-04 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$2.09 10-Q · filed 2025-11-04 | $1.82 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-06-30 | -$0.58 10-Q · filed 2025-08-11 | -$1.26 10-Q · filed 2025-08-11 | $2.80 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.09 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-03-31 | -$0.69 10-Q · filed 2025-05-09 | $3.57 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.85 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.27 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-12-31 | $4.78 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.88 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.22 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.52 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.90 10-Q · filed 2024-10-31 | -$1.57 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$2.27 10-Q · filed 2024-10-31 | $2.44 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-06-30 | -$0.67 10-Q · filed 2024-08-07 | -$1.37 10-Q · filed 2024-08-07 | $3.35 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.66 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-03-31 | -$0.70 10-Q · filed 2024-05-02 | $4.03 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.35 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.71 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-12-31 | $4.74 derived: net income ÷ weighted average shares · filed 2026-04-29 | $4.12 derived: net income ÷ weighted average shares · filed 2026-04-29 | $3.50 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.87 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.79 10-Q · filed 2023-11-02 | -$1.57 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$2.28 10-Q · filed 2023-11-02 | $0.89 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-06-30 | -$0.78 10-Q · filed 2023-08-03 | -$1.49 10-Q · filed 2023-08-03 | $1.74 derived: net income ÷ weighted average shares · filed 2026-04-29 | $1.19 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-03-31 | -$0.71 10-Q · filed 2023-05-04 | $2.52 derived: net income ÷ weighted average shares · filed 2026-04-29 | $1.98 derived: net income ÷ weighted average shares · filed 2026-04-29 | $1.54 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2021-12-31 | $3.24 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.70 derived: net income ÷ weighted average shares · filed 2026-04-29 | $2.31 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.09 10-K · filed 2024-02-22 |
| 2021-09-30 | -$0.56 10-Q · filed 2022-11-03 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.42 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.55 10-Q · filed 2022-08-09 | -$0.84 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | -$3.15 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |